¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"side chain theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • food chain
    ¸ÔÀ̻罽
  • gamma chain disease
    °¨¸¶»ç½½º´
  • heavy chain
    ¹«°Å¿î»ç½½, Áß¼â
  • heavy-chain disease
    ¹«°Å¿î»ç½½º´, Á߼⺴
  • hemolytic chain
    ¿ëÇ÷»ç½½
  • joining chain
    ¿¬°á»ç½½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • open chain
    ¿­¸°»ç½½
  • open-chain compound
    (¢¡open chain) ¿­¸°»ç½½
  • oxidative chain
    »êÈ­¿¬¼â
  • respiratory chain
    È£Èí»ç½½
  • reverberating chain
    ¹ÝÇâ»ç½½
  • sympathetic chain
    (¢¡sympathetic trunk) ±³°¨½Å°æÁÙ±â
  • gamma chain disease
    °¨¸¶°í¸®º´
  • heavy-chain disease
    Áß°í¸®º´
  • nuclear chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • open chain form
    ¿­¸°»ç½½Çü
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • alternation theory
    ±³¹ø¼³
  • backward failure theory
    ÈĹæÀå¾Ö¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain disease
    H¼âº´(¡­áðÜ»), Á߼⺴(ñìáðÜ»).
  • heavy chain disease
    Áß ¼âº´
  • heavy-chain disease
    Á߼⺴
  • hemoglobin a,b-globin chain of
    ¥â-±Û·Îºó¼â(¡­áð)
  • hemolytic chain
    ¿ëÇ÷¿¬¼â.
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alpha (¥á) chain
    ¾ËÆÄ»ç½½, ¾ËÆÄ¼â
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • atomic chain
    ¿øÀÚ¼â(ê«í­áð).
  • beta (¥â) chain
    º£Å¸»ç½½, º£Å¸¼â
  • branched chain amino acid
    ºÐÁö¼â¾Æ¹Ì³ë»ê
  • chain
    »ç½½, ¼â
  • chain
    ¿¬¼â(ææáð), ¼â(áð), °í¸®, »ç½½.
  • chain combination
    ¿¬¼â°áÇÕ.
  • chain compound
    »ç½½È­ÇÕ¹°.
  • chain cystourethrography
    °í¸® ¹æ±¤¿äµµ Á¶¿µ¼ú
  • chain fiber
    ¿¬¼â¼¶À¯(ææáðàéë«)
  • chain index
    ¿¬¼âÁö¼ö.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • electron transport chain
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) »ç½½
  • end carbon chain
    ³¡Åº¼Ò(÷©áÈ) »ç½½
  • epsilon chain
    ÀԽǷР»ç½½
  • equivalent chain length
    µî(Ôõ)»ç½½ ±æÀÌ
  • food chain
    ¸ÔÀÌ »ç½½
  • gamma chain
    °·¸¶ »ç½½
  • Gaussian chain
    °¡¿ì½º »ç½½
  • H chain
    H »ç½½
  • heavy chain
    Áß(ñì)»ç½½
  • heavy-chain class switching
    Áß(ñì)»ç½½ À¯(×¾) ¹Ù²Ù±â
  • heavy-chain disease
    Áß(ñì)»ç½½ Áúȯ(òðü´)
  • immunoglobulin chain
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° »ç½½
  • J chain
    J »ç½½
  • kappa chain
    Ä«ÆÄ»ç½½
  • lambda chain
    ¶÷´Ù »ç½½
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LC Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf...
VH variable domain of heavy chain; variable heavy chain
VL variable domain of the light chain; variable light chain
SE Side Effect
ABS abdominal surgery; acute brain syndrome; Adaptive Behavior Scale; admitting blood sugar; adult bovin...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TOM Theory of Mind
TPB Theory of Planned Behavior
TRA Theory of Reasoned Action
EPS Extrapyramidal side effects
SSC Side scatter
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nonallergic side effect
    ºñ¾Ë·¹¸£±â¼º ºÎÀÛ¿ë
  • nonworking side interference
    ºñÀÛ¾÷Ãø °£¼·
    ÇϾÇÀÌ Ãø¹æ ¿îµ¿À» ÇÏ¿´À» ¶§ ±× ¿îµ¿ ¹æÇâ°ú ¹Ý´ëÆíÀÇ »ó, ÇÏ¾Ç ±¸Ä¡ºÎ »çÀÌÀÇ ±³ÇÕ Á¢ÃË.
  • side bending movement
    Ãø¹æ ±ÁÈû ¿îµ¿
  • side effect
    ºÎÀÛ¿ë
    »ç¿ëµÈ ¾àǰÀ̳ª ¾àÁ¦°¡ ¸ñÀû ÀÌ¿ÜÀÇ ´Ù¸¥ °á°ú, Áï ¹Ý´ë ÀÛ¿ëÀ¸·Î ¾à¹°¿¡ ´ëÇÑ À¯ÇØ ÀÛ¿ë, ƯÈ÷ ±× Åõ¿©·Î È¿´ÉÀ» Ãß±¸ÇÏ´Â °Í°ú ´Ù¸¥ Á¶Á÷À̳ª ±â°ü °èÅë¿¡ ¹ÌÄ¡´Â ÇØ·Î¿î ¿µÇâ°ú °°Àº °Í.
  • side lobe artifact
    Ãø¿± Àΰø¹°
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
  • side view
    Ãø¸éµµ
  • side-shift plate
    Bennett plates
    Whi
  • working side condyle
    ÀÛ¾÷Ãø °úµÎ
    ÇϾÇÀÇ ±â´ÉÃøÀÇ °úµÎ¸¦ ¸»ÇÔ.
  • working side contact
    ÀÛ¾÷Ãø Á¢ÃË
    ÀúÀÛÀ» ÇÏ°Ô µÇ´Â ±â´ÉÃøÀÇ Ä¡¾Æ°¡ Á¢ÃËÇÑ °ÍÀ» ÀǹÌÇÔ. ±â´ÉÃøÀÇ Ä¡¾Æ°¡ Á¢ÃËÇÒ ¶§, ¹Ý´ëÃøÀÇ Ä¡¾Æ´Â À̰³ÇÏ°Ô µÈ´Ù.
  • acid decalcification theory
    Żȸ¼³
    ¿ì½ÄÀÇ º´Àο¡ °üÇÑ ¼³·Î ¼¼±ÕÀ» »ý»êÇÏ´Â »ê ȤÀº ´çºÐÀ» Æ÷ÇÔÇÑ À½½Ä¹°ÀÇ Àܻ翡 ¹ßÈ¿¿¡ ÀÇÇÏ¿© »ý±ä »êÀÌ Ä¡ÁúÀ» ŻȸÇÏ¿© ¿ì½ÄÀÌ »ý±ä´Ù´Â ¼³.
  • acidogenic theory
    »êÀηÐ, »ê»ý¼º ÀÌ·Ð, È­ÇÐ ¼¼±Õ¼³
    Ä¡¾Æ ¿ì½ÄÀº chemico-
  • aging,free radical theory
    À¯¸®±â¼³
  • alternation theory
    ±³¹ø¼³
  • apposition theory
    ºÎÂø¼³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
medium-chain acyl-CoA dehydrogenase <enzyme> Deficiency in mitochondrial beta oxidation of fatty acids gives a disorder frequently masquerading as reye syndrome or sudden infant death; leads to buildup of octanoyl carnitine in urine
Registry number: EC 1.3.-
Synonym: mcaca-dehydrogenase, medium-chain acyl-coenzyme a dehydrogenase, octanoyl-CoA dehydrogenase, mcad enzyme
(26 Jun 1999)
respiratory chain The mitochondrial electron transport chain.
(18 Nov 1997)
glycyl chain A polypeptide component of insulin containing 21 amino acyl residues, beginning with a glycyl residue (NH2-terminus); insulin is formed by the linkage of an A chain to a B chain by two disulfide bonds; the amino-acid composition of the A chain is a function of species.
Synonym: glycyl chain.
In general, one of the polypeptides in a multiprotein complex.
(05 Mar 2000)
peptide chain elongation The process whereby an amino acid is joined through a substituted amide linkage to a chain of peptides.
(12 Dec 1998)
peptide chain initiation The process whereby the formation of a peptide chain is started. This process requires (1) the 30s subunit, (2) the mRNA coding for the polypeptide to be made, (3) met-trnai, (4) initiation factors, and (5) GTP.
(12 Dec 1998)
peptide chain termination The process whereby the last amino acid is added to a polypeptide. This termination is signaled by one of three termination triplets in the mRNA, immediately following the last amino acid codon.
(12 Dec 1998)
chain 1. In chemistry, a series of atoms held together by one or more covalent bonds.
2. In bacteriology, a linear arrangement of living cells that have divided in one plane and remain attached to each other.
Origin: L. Catena
(05 Mar 2000)
chain-compensated spirometer A Tissot spirometer in which compensation for change in bell buoyancy is accomplished automatically by a suspending chain of correct mass per unit length.
(05 Mar 2000)
chain isomer <chemistry> One of two or more compounds having the same chemical composition but differing in the arrangement of the atoms (usually carbon atoms) forming the backbone of the structure of the compounds.
(21 Mar 1998)
chain reaction A reaction in which a product reacts and thus continues the reaction.
(09 Oct 1997)
chain reflex A series of reflexs, each serving as a stimulus for the next.
(05 Mar 2000)
phenylalanyl chain A polypeptide component of insulin containing 30 amino acyl residues, beginning with a phenylalanyl residue (NH2-terminus); insulin is formed by the linkage of a B chain to an A chain by two disulfide bonds; the amino-acid composition of the B chain is a function of species.
Synonym: phenylalanyl chain.
(05 Mar 2000)
closed chain compound Any compound in which the constituent atoms, or any part of them, form a ring. Used mainly in organic chemistry where: 1) numerous compound's contain rings of carbon atoms (carbocyclic compound's) or carbon atoms plus one or more atoms of other types (heterocyclic compound's), usually nitrogen, oxygen, or sulfur; 2) where the atoms in the ring are all of the same element (homocyclic or isocyclic compound); 3) where the ring is saturated or contains nonconjugated double bonds (alicyclic compound), the compound is similar in properties to the corresponding acyclic compound (e.g., cyclohexane resembles hexane); 4) where the ring contains conjugated double bonds in a closed loop in which there are 4n + 2 (where n is an integer) delocalised &pi; electrons (Huckel's rule) (aromatic compound; e.g., benzene, pyridine), it is more stable than the corresponding saturated ring and exhibits unusual chemical properties characteristic of itself and not of other types of rings or of acyclic compound's. These aromatic compounds have the ability to sustain an induced ring current.
Synonym: closed chain compound, ring compound.
(05 Mar 2000)
cold chain A system of protection against high environmental temperatures for heat-labile vaccines, sera and other biological preparations.
(05 Mar 2000)
P light chain <protein> Myosin light chain that can be phosphorylated by myosin light chain kinase, as a result of phosphorylation, the myosin is activated.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • East Side
    ´º¿å Manhattan¼¶ µ¿ºÎÀÇ ÇÏÃþ À̹ΠÁö±¸
  • credit side
    ´ëº¯
  • day side
    (½Å¹®»çÀÇ)¼®°£ ¿ä¿ø;ÁÖ°£ ±Ù¹«ÀÚ
  • day side
    (õ)ÇÞºûÀ» ¹Þ´Â Ç༺(´Þ)ÀÇ ¹Ý±¸;³·ÀÌ µÇ´Â ÂÊ
  • distaff side
    ¸ð°è;¾î¸Ó´Ï ÂÊ
  • epistle side
    (Á¦´ÜÀÇ)³²ÂÊ;(Á¦´ÜÀ» ÇâÇØ)¿À¸¥ÂÊ
  • flesh side
    °¡Á×ÀÇ µÞ¸é(»ìÀÌ ºÙÀº ÂÊ)
  • flip side
    ·¹ÄÚµåÀÇ B¸é
  • gospel side
    º¹À½¼­ÂÊ
  • grain side
    (Áü½Â °¡Á×ÀÇ)ÅÐÀ» ÀÖ´Â ÂÊ
  • no side
    ·°ºñ °æ±â³¡(½ÉÆÇ¿ë¾î)
  • off side
    ¹Ý´ëÃøÀÇ;¿ÀÇÁ»çÀ̵åÀÇ
  • prompt side
    ÇÁ·ÒÇÁÅͰ¡ ÀÖ´Â ÂÊ(°´¼®¿¡¼­ º¸¾Æ ¿ÞÂÊÀÌ¸ç ¹è¿ìÀÇ ¿À¸¥ÂÊÀÓ)
  • re-side
    (Áý¾ÈÀÇ)ÆÇº®À» °¥¾Æ³¢¿ì´Ù
  • side
    ÂÊ;°Ñ;º¯µÎ¸®;Ç÷Åë;Àß³­Ã¼Çϱâ;¿·±¸¸®;(ÀûÆí,¿ì¸®ÆíÀÇ)Æí;ÀÚ±âÆí;°¡;³¡;º¯µÎ¸®;(¾Æ¹öÁöÂÊ,¾î¸Ó´ÏÂÊÀÇ)ÂÊ;°è;Ç÷Åë;by the ~ of;...ÀÇ °ç¿¡;...¿Í ºñ±³ÇÏ¿©;change ~s º¯ÀýÇÏ´Ù;on the large ~ Á» Å«ÆíÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á